Image Credit: Yandex

In the realm of cardiovascular medicine, Entresto represents a hallmark in the treatment of heart failure. As a combination drug that tackles heart failure head-on, understanding what is Entresto used for and why is it crucial for patients and healthcare providers alike. Its role in managing symptoms, improving quality of life, and potentially extending the lifespan of those with heart failure marks a significant advancement. Moreover, its application in the context of blood pressure management reveals its versatility and importance in the broader spectrum of cardiovascular health.

This article delves into the mechanism of action of Entresto, shedding light on how it benefits the heart and circulatory system. We will explore its FDA approvals and warnings to ensure readers are well-informed about its uses and the precautions necessary when considering it as a treatment option. Inspection of its instructions for use will provide clear guidance for patients, ensuring maximum effectiveness while minimizing risks such as low blood pressure or allergic reactions. Additionally, the interactions with other drugs will be scrutinized to guard against potential complications in patients with hypertension, hypotension, diabetes, and other conditions. By unraveling the layers of Entresto’s functionality and safety, this article aims to equip readers with the knowledge needed to discuss its potential benefits and side effects with their healthcare provider thoughtfully.

Mechanism of Action

How Sacubitril Works

Sacubitril, a component of Entresto, functions primarily as a neprilysin inhibitor. By inhibiting neprilysin, Sacubitril prevents the breakdown of natriuretic peptides. These peptides are crucial for reducing strain on the heart as they promote vasodilation and enhance the excretion of sodium and fluid through urine. This action not only helps in lowering blood pressure but also aids in preventing myocardial fibrosis and improving heart function by reducing cardiomyocyte cell death and hypertrophy.

How Valsartan Works

Valsartan, the other active ingredient in Entresto, operates as an angiotensin II receptor blocker (ARB). It effectively blocks the receptors for angiotensin II, a hormone that causes vasoconstriction and promotes sodium and fluid retention. By blocking these receptors, Valsartan helps to reduce blood pressure and prevent harmful effects on the heart, which are particularly detrimental in the context of heart failure. Additionally, it contributes to the prevention of kidney damage, a common complication of heart failure.

Combined Effect on the Heart

The dual mechanism of Entresto, through the combined actions of Sacubitril and Valsartan, offers a synergistic benefit to patients suffering from heart failure. While Sacubitril enhances the protective natriuretic peptide effects, Valsartan counters the adverse effects of angiotensin II. Together, they work to prevent cardiac remodeling, reduce myocardial stress and injury, and improve overall cardiac function. This combination not only improves the quality of life for patients but also has the potential to extend it by mitigating the progression of heart failure.

FDA Approvals and Warnings

Approved Uses

Entresto is approved to reduce the risk of cardiovascular death and hospitalization in adult patients with chronic heart failure, particularly those with a left ventricular ejection fraction (LVEF) below normal. This approval extends to the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older, where it is expected to improve cardiovascular outcomes by reducing NT-proBNP levels.

On July 7, 2015, the US Food and Drug Administration (FDA) approved the combination of sacubitril and valsartan (Entresto; Novartis) for these indications. This marked the first approval of an angiotensin receptor neprilysin inhibitor for this purpose, highlighting a significant advancement in treatment options for patients with heart failure classified as NYHA Class II-IV.

Boxed Warning for Fetal Harm

Entresto carries a serious boxed warning regarding fetal toxicity. When pregnancy is detected, Entresto must be discontinued as soon as possible. The medication can cause injury and even death to the developing fetus, primarily due to its effects on the renin-angiotensin system. This system plays a critical role in fetal development, and interference can result in significant adverse outcomes.

Additionally, Entresto may cause angioedema, a severe allergic reaction characterized by swelling of the face, lips, tongue, and throat, which can obstruct breathing and become life-threatening. This risk necessitates careful monitoring and immediate medical response if symptoms of angioedema appear.

Also Read: Mullein Leaf Extract: Dosage, Benefits, and Precautions

Instruction for Use

How to Take Entresto

Entresto is prescribed to be taken orally, typically twice daily, to manage heart failure. Patients should swallow the tablets whole with a glass of water and can take them with or without food. It is crucial to adhere to the prescribed dosage and schedule to optimize treatment efficacy and minimize risks. For those who have difficulty swallowing tablets, Entresto oral suspension or Entresto SPRINKLE, which are oral pellets contained within capsules, can be used. To administer the oral pellets, open the capsule and sprinkle the contents onto soft food, consuming immediately.

When transitioning from an angiotensin-converting enzyme (ACE) inhibitor to Entresto, a 36-hour washout period is necessary to avoid adverse interactions. Starting doses and subsequent adjustments should be carefully managed according to patient tolerance, with initial lower doses recommended for those new to ACE inhibitors or angiotensin II receptor blockers (ARBs), and for patients with severe renal impairment or moderate hepatic impairment.

Diet and Lifestyle Considerations

While taking Entresto, patients are advised to manage their diet and lifestyle to support treatment outcomes. This includes avoiding nonsteroidal anti-inflammatory drugs (NSAIDs) and being cautious of low-salt substitutes that may have high potassium content, as these can increase the risk of hyperkalemia. Regular monitoring of potassium levels is recommended if potassium-containing products are used.

Patients should also avoid alcohol or be cautious as it can exacerbate the blood pressure-lowering effects of Entresto, potentially leading to dizziness and fainting. It is important to maintain hydration but avoid excessive fluid intake that could lead to heart failure exacerbation. Following a heart-healthy diet, engaging in appropriate physical activity, and managing other health conditions such as diabetes or high cholesterol are also crucial.

Patients must report any signs of angioedema or unusual symptoms such as lightheadedness or symptoms of low blood pressure to their healthcare provider promptly. Regular follow-ups to monitor the effectiveness of the medication and any potential side effects are essential to ensure safe and effective treatment with Entresto.

Also Read: CoolSculpting Cost: Everything You Need to Know

Interactions with Other Drugs

ACE Inhibitors

Entresto should not be taken with angiotensin-converting enzyme (ACE) inhibitors due to the increased risk of angioedema, a severe allergic reaction that can cause swelling of the deeper layers of the skin, potentially affecting the airways and leading to difficulty breathing. Examples of ACE inhibitors include Lisinopril, Enalapril, and Ramipril. It is crucial to allow a 36-hour washout period between discontinuing an ACE inhibitor and starting Entresto to avoid this severe interaction.

Potassium Supplements

Entresto can raise potassium levels in the blood, leading to hyperkalemia, a condition that can cause muscle paralysis, irregular heart rhythms, and in severe cases, cardiac arrest. Patients are advised against using potassium-containing salt substitutes or over-the-counter potassium supplements without consulting their doctor. High potassium levels can cause symptoms like weakness, confusion, and irregular heartbeat. Regular monitoring of potassium levels is recommended when on Entresto.

Other Interactions

Entresto has potential interactions with nonsteroidal anti-inflammatory drugs (NSAIDs), which can increase the risk of kidney problems, including acute kidney failure. Additionally, interactions with lithium used in treating mental health conditions like bipolar disorder can lead to increased lithium levels in the blood, enhancing the risk of lithium toxicity. Symptoms of lithium toxicity include tremors, blurred vision, and coordination problems. Patients taking both Entresto and lithium should have their lithium levels closely monitored to manage any potential side effects effectively.

Conclusion

Throughout this discussion, we’ve explored the critical role of Entresto in the realm of cardiovascular health, specifically highlighting its benefits for patients suffering from heart failure. By understanding the dual mechanisms of Sacubitril and Valsartan, we can appreciate how Entresto not only improves heart function but also has the potential to extend life expectancy by mitigating heart failure progression. Patients and healthcare providers alike must be well-acquainted with the nuances of this medication, including the importance of adhering to FDA guidelines, being mindful of dietary and lifestyle considerations, and recognizing the signs of potential side effects or drug interactions.

The broader implications of Entresto’s use, particularly its FDA approval for reducing cardiovascular death and hospitalization risks, underscore a significant advancement in heart failure treatment. However, the boxed warning for fetal harm and the critical considerations surrounding drug interactions remind us of the care needed when prescribing and managing Entresto therapy. As we navigate the complex landscape of heart failure treatment, Entresto emerges as a beacon of hope, yet it also demands a comprehensive understanding and judicious use. Encouraging further research and informed discussions between patients and healthcare providers will continue to enhance the therapeutic outcomes associated with Entresto and enrich the quality of life for those affected by heart failure.

FAQs

What are the advantages of using Entresto? Entresto is prescribed for treating specific types of heart failure. It has been shown to potentially extend life and reduce the likelihood of hospitalization due to heart failure. Entresto combines two medications: sacubitril and valsartan.

What are the typical side effects experienced with Entresto? The most common side effects of Entresto include dizziness, fainting, light-headedness, cough, headache, diarrhea, nausea, stomach pain, tiredness, and weakness. More severe side effects can involve swelling of the face, lips, tongue, and/or throat, as well as difficulties in breathing and swallowing.

Is Entresto considered a high-risk medication? Yes, Entresto carries a boxed warning, which is the sternest warning issued by the Food and Drug Administration (FDA). This warning is meant to alert both doctors and patients to the potential severe risks of the drug, including fetal toxicity, which can harm an unborn baby if taken during pregnancy.

Are there any supplements that should be avoided while taking Entresto? Entresto may interact adversely with potassium supplements, causing the potassium levels in your blood to rise excessively. It is advised not to take potassium supplements while on Entresto unless explicitly directed by your doctor.